April 20, 2018 / 8:05 AM / 5 months ago

BRIEF-Hikma Pharmaceuticals Says US Subsidiary Launches Dexrazoxane For Injection

April 20 (Reuters) - Hikma Pharmaceuticals PLC:

* HIKMA LAUNCHES DEXRAZOXANE FOR INJECTION

* US SUBSIDIARY WEST-WARD PHARMACEUTICALS, LAUNCHED DEXRAZOXANE FOR INJECTION, 250MG AND 500MG VIALS, GENERIC EQUIVALENT TO ZINECARD Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below